FDA Inspection 1255158 — Innogenix, LLC.

Innogenix, LLC. — FEI 3013326213

The FDA completed an inspection of Innogenix, LLC. on November 15, 2024 in Amityville, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
November 15, 2024
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Amityville, NY (United States)